Diagnostic and Interventional Cardiology

Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods

Multicenter Validation of the Novel Vivio System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure

November 15, 2023 — Ventric Health, a healthcare technology company and medical device provider focused on ...

November 15, 2023

The global medical technology leader and international medical imaging IT and cybersecurity company are working together to provide clinicians with a thorough workflow integration that spans from orchestration and diagnostics to report generation and result distribution

News | Information Technology

GE HealthCare and Sectra Plan to Leverage Deep Integration to Help Enhance Clinical Efficiency

November 14, 2023 — To help provide clinicians a comprehensive workflow, GE HealthCare is working towards the seamless ...

November 14, 2023

The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science

News | Heart Failure

American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award

November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher ...

November 14, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | Artificial Intelligence

Breakthrough Clinical Data: Eko Health's AI Significantly Improves Heart Disease Detection in Primary Care

November 14, 2023 — Eko Health, Inc., a leader in AI technology for heart and lung disease detection, today unveiled new ...

November 14, 2023

Sponsored Content | Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Visage introduces Visage 7, Cardiology Imaging and Visage 7 RadPath Hub

News | PACS

Visage Soars with CloudPACS at RSNA 2023

November 13, 2023 — Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced it will be ...

November 13, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias

News | AHA

Exciting New Applications of vMap for Ventricular Arrhythmias Highlighted at AHA 2023

November 13, 2023 — Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two ...

November 13, 2023

Ultromics, a leading health technology company at the forefront of detection of heart failure and its phenotypes, announces a significant development regarding the reimbursement code for its flagship product, EchoGo Heart Failure.

News | Heart Failure

CMS publishes final Clinical APC rule for Ultromics EchoGo Heart Failure

November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and ...

November 13, 2023

Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023, AHA 2023, which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-75% of participants in as little as one week

News | AHA

Reducing Sodium Intake Significantly Lowered Blood Pressure in as Little as One Week, Reports AHA 2023 Late-Breaking Science Abstract

November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific ...

November 11, 2023

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.

News | AHA

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association AHA 2023 Scientific Sessions

November 11, 2023 — An announcement on partners to collaborate in the TRANSFORM trial was made today during the American ...

November 11, 2023

Getinge announced commercial availability of the iCast covered stent system in the United States

News | Peripheral Artery Disease (PAD)

Getinge Announces U.S. Commercial Availability of iCast Covered Stent System for Treatment of Iliac Arterial Occlusive Disease

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

November 10, 2023

Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint

News | Cardiovascular Clinical Studies

Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease

November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to ...

November 10, 2023

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.

News | Atrial Fibrillation

Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023

November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at ...

November 10, 2023

News | Artificial Heart

Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference

November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has ...

November 10, 2023

Further enhancing comprehensive trauma care solution

News | Artificial Intelligence

RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas

November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions ...

November 09, 2023